Douglas E Coltharp
CIK 1186879 · EVP & Chief Financial Officer · last filed 2026-10-02
Douglas E Coltharp is an EVP & Chief Financial Officer who has filed 246 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for UA, was dated Oct 2, 2026. Across all open-market trades the lifetime net is −$20.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.2M across reported positions. 89 SEC filings were submitted jointly with Encompass Health Corp.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EHC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1020 HULL STREET
BALTIMORE, MD 21230
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UA | Director | 77,734 | $5.32 | $413.2K | $0 | 3 | 2026-10-02 |
| EHC | EVP & Chief Financial Officer | 77,988 | $140.39 | $10.95M | -$14.98M | 52 | 2026-08-11 |
| UARM | Director | 55,320 | — | — | -$2.77M | 109 | 2026-04-02 |
| UAA | Director | 317,690 | $5.50 | $1.75M | $0 | 39 | 2026-04-02 |
| Encompass Health Corp (HLS) Delisted | EVP & Chief Financial Officer | 115,815 | — | — | $0 | 23 | 2017-02-27 |
| Encompass Health Corp (HLS.WS) Delisted | EVP & Chief Financial Officer | 99,974 | — | — | $252.5K | 7 | 2017-01-05 |
| rue21, inc. (RUE) Delisted | Director | — | — | — | $0 | 1 | 2009-11-18 |
| ARCC | Director | 4,500 | $19.36 | $87.1K | $42.5K | 2 | 2008-11-17 |
| SAKS INC (SKS) Delisted | EVP and CFO | 69,411 | — | — | -$3.35M | 5 | 2007-05-08 |
Recent Filings
246 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-02 | UA | Grant (A) | +7,864 | $0 | EDGAR |
| 2026-09-02 | UA | Grant (A) | +29,880 | $0 | EDGAR |
| 2026-08-11 | EHC | Sell (S) | −18,869 | -$2.37M | EDGAR |
| 2026-08-10 | EHC | Notice (144) | −18,869 | -$2.37M | EDGAR |
| 2026-07-06 | UA | Grant (A) | +5,575 | $0 | EDGAR |
| 2026-05-18 | EHC | Mixed | — | -$2.05M | EDGAR |
| 2026-05-15 | EHC | Notice (144) | −27,694 | -$2.96M | EDGAR |
| 2026-04-02 | UARM | Grant (A) | +6,361 | $0 | EDGAR |
| 2026-04-02 | UAA | Grant (A) | +6,361 | $0 | EDGAR |
| 2026-03-03 | EHC | Mixed | −776 | -$83.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.